GlassScriptPhysician profile
Michael O Growney
NPI 1851437636
$4,168.95
in general payments reported to CMS, 2019-2025
23 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $132 · 2021: $3,207 · 2022: $108 · 2023: $287 · 2024: $85.99 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $484.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $3,111.07 | 2019-2024 | Acessa Provu System, Myosure Tissue Removal Device, Coolseal Generator |
| Bayer Healthcare Pharmaceuticals INC. | $160.70 | 2019-2023 | |
| Coloplast Corp | $154.62 | 2023-2025 | Saffron, Altis |
| Abbvie INC. | $133.18 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $75.27 | 2019-2023 | Gardasil 9 |
| Evofem Biosciences, INC. | $55.50 | 2021 | |
| Roche Diagnostics Corporation | $52.51 | 2019-2021 | |
| Exeltis, USA INC. | $49.03 | 2023 | Slynd |
| Organon LLC | $44.59 | 2022-2024 | Nexplanon |
| Ethicon US, LLC | $40.04 | 2019-2021 | |
| Pfizer INC. | $32.29 | 2019-2021 | |
| Abbott Laboratories | $32.06 | 2021 | |
| Coopersurgical, INC. | $31.79 | 2019-2023 | Summit Doppler |
| Agile Therapeutics, INC. | $30.53 | 2021-2024 | Twirla |
| Axonics, INC. | $30.42 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $23.09 | 2023 | Myfembree |
| Myovant Sciences INC. | $20.08 | 2021 | |
| Amgen INC. | $19.01 | 2020 | |
| Aspira Women'S Health INC | $17.45 | 2020 | |
| Medtronic, INC. | $17.24 | 2023 | Interstim |
| Allergan, INC. | $13.94 | 2019 | |
| Amag Pharmaceuticals, INC. | $13.15 | 2019 | |
| Therapeuticsmd, INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Growney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.